Global Biopsy Guidance System Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3600/- USD | Published Date: July 12, 2021 |

The global biopsy guidance system market size is expected to register a positive CAGR of over 5% during the forecast period 2021 to 2027 and was valued at around USD 1 billion in 2020. The rising prevalence of cancer cases around the globe is a primary factor to drive the market growth. as per the latest information shared by IARC (International Agency for Research on Cancer), over 19 million new cancer cases were registered in 2020 and 10 million deaths were recorded due to the cancer disease.

The growing preference for non-invasive procedures and the increasing geriatric population are other factors to boost the market. Furthermore, the technological advancement in medical devices and increasing government initiatives around the world are expected to fuel the market growth over the forecast period. The governments of various countries are working for cancer awareness and health benefits of early detection of diseases through screening services.

Market Segment Insights:

The global biopsy guidance system market is bifurcated into product, application, end-use, and geography. Based on the product, the market is further segmented into stereotactic, ultrasound, and MRI-guided biopsy. The stereotactic guided biopsy segment dominated the market in 2020 and accounted for the largest revenue share of around 40% of the market. The segment growth is attributed to the benefits associated with this biopsy such as less invasive, rapid recovery, and causes minimal scarring. On the other hand, the ultrasound-guided biopsy segment is expected to grow at the fastest growth rate over the forecast period.

Biopsy Guidance System Market Size

To know more about the report, request sample papers

Based on application, the market is classified into brain biopsy, breast biopsy, and other applications. The breast biopsy segment is expected to grow at the fastest CAGR over the forecast period due to the increasing cases of breast cancer among women. According to WHO (World Health Organization), around 2.26 million new cases are recorded as breast cancer in 2020. In contrast, the brain biopsy segment dominated the global biopsy guidance systems market in 2020 and accounted to hold the largest revenue share of over 42% in 2020. The segment growth is attributed to the increasing cases of brain cancer across the globe.

The biopsy guidance system comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2021 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market, and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The biopsy guidance system market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2018-19 – Historical Year
  • 2020 – Base Year
  • 2021-2027 – Forecast Period

Global Biopsy Guidance System Market Segmentation:

By Product:

  • Stereotactic Guided Biopsy
  • Ultrasound-Guided Biopsy
  • MRI Guided Biopsy

By Application:

  • Brain Biopsy
  • Breast Biopsy
  • Other Applications

By End-Use:

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Research and Academic Institutes

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

Geographically, North America dominated the market in 2020 and accounted to hold the largest market share around half the global market. The introduction of new advanced biopsy guidance systems and increasing incidence of cancer cases are major factors driving the region’s biopsy guidance system market. The rising demand for innovative treatments and expansion of cancer diagnostics centers is further expected to boost the market growth in North America. Moreover, the increasing investment in research and development by the government and other organizations is expected to support the market in North America.

Market Competition Assessment:

Some of the major players operating in the global biopsy guidance system market are Becton, Dickinson and Company, Hologic, Inc., ARGON MEDICAL, B. Braun Melsungen AG, and Devicor Medical Products, Inc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Becton, Dickinson, and Company
  • Hologic, Inc.
  • ARGON MEDICAL
  • Braun Melsungen AG
  • Devicor Medical Products, Inc.
  • Boston Scientific Corporation
  • INRAD Inc.
  • Cook Medical
  • PLANMED OY

Key Questions Answered by Biopsy Guidance System Market Report

  • Global biopsy guidance system market forecasts from 2021-2027
  • Regional biopsy guidance system market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
  • Biopsy guidance system submarket forecasts from 2021-2027 covering the market by product, by application, by end-use, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis of biopsy guidance system market
  • Analysis of the key factors driving and restraining the growth of the global, regional, and country-level biopsy guidance system markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the biopsy guidance system market
Table of Content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Biopsy Guidance System Market Portraiture
2.2. Global Biopsy Guidance System Market, by Product, 2020 (USD Mn)
2.3. Global Biopsy Guidance System Market, by Application, 2020 (USD Mn)
2.4. Global Biopsy Guidance System Market, by End-Use, 2020 (USD Mn)
2.5. Global Biopsy Guidance System Market, by Geography, 2020 (USD Mn)

 

3. Global Biopsy Guidance System Market Analysis


3.1. Biopsy Guidance System Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis
3.6.1. V Shaped Recovery
3.6.2. U Shaped Recovery
3.6.3. L Shaped Recovery
3.6.4. W Shaped Recovery

 

4. Global Biopsy Guidance System Market By Product, 2018 – 2027 (USD Mn)


4.1. Overview
4.2. Stereotactic Guided Biopsy
4.3. Ultrasound Guided Biopsy
4.4. MRI Guided Biopsy

 

5. Global Biopsy Guidance System Market By Application, 2018 – 2027 (USD Mn)


5.1. Overview
5.2. Brain Biopsy
5.3. Breast Biopsy
5.4. Other Applications

 

6. Global Biopsy Guidance System Market By End-Use, 2018 – 2027 (USD Mn)


6.1. Overview
6.2. Hospitals
6.3. Specialty Clinics
6.4. Diagnostic Centers
6.5. Research and Academic Institutes

 

7. North America Biopsy Guidance System Market Analysis and Forecast, 2018 – 2027 (USD Mn)


7.1.1. Overview
7.1.2. North America Biopsy Guidance System Market by Product (2018-2027 USD Mn)
7.1.3. North America Biopsy Guidance System Market by Application (2018-2027 USD Mn)
7.1.4. North America Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)
7.1.5. North America Biopsy Guidance System Market by Country (2018-2027 USD Mn)
7.1.5.1. U.S.
7.1.5.1.1. U.S. Biopsy Guidance System Market by Product (2018-2027 USD Mn)
7.1.5.1.2. U.S. Biopsy Guidance System Market by Application (2018-2027 USD Mn)
7.1.5.1.3. U.S. Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)
7.1.5.2. Canada
7.1.5.2.1. Canada Biopsy Guidance System Market by Product (2018-2027 USD Mn)
7.1.5.2.2. Canada Biopsy Guidance System Market by Application (2018-2027 USD Mn)
7.1.5.2.3. Canada Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)

 

8. Europe Biopsy Guidance System Market Analysis and Forecast, 2018 – 2027 (USD Mn)


8.1.1. Overview
8.1.2. Europe Biopsy Guidance System Market by Product (2018-2027 USD Mn)
8.1.3. Europe Biopsy Guidance System Market by Application (2018-2027 USD Mn)
8.1.4. Europe Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)
8.1.5. Europe Biopsy Guidance System Market by Country (2018-2027 USD Mn)
8.1.5.1. Germany
8.1.5.1.1. Germany Biopsy Guidance System Market by Product (2018-2027 USD Mn)
8.1.5.1.2. Germany Biopsy Guidance System Market by Application (2018-2027 USD Mn)
8.1.5.1.3. Germany Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)
8.1.5.2. U.K.
8.1.5.2.1. U.K. Biopsy Guidance System Market by Product (2018-2027 USD Mn)
8.1.5.2.2. U.K. Biopsy Guidance System Market by Application (2018-2027 USD Mn)
8.1.5.2.3. U.K. Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)
8.1.5.3. France
8.1.5.3.1. France Biopsy Guidance System Market by Product (2018-2027 USD Mn)
8.1.5.3.2. France Biopsy Guidance System Market by Application (2018-2027 USD Mn)
8.1.5.3.3. France Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)
8.1.5.4. Italy
8.1.5.4.1. Italy Biopsy Guidance System Market by Product (2018-2027 USD Mn)
8.1.5.4.2. Italy Biopsy Guidance System Market by Application (2018-2027 USD Mn)
8.1.5.4.3. Italy Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)
8.1.5.5. Rest of Europe
8.1.5.5.1. Rest of Europe Biopsy Guidance System Market by Product (2018-2027 USD Mn)
8.1.5.5.2. Rest of Europe Biopsy Guidance System Market by Application (2018-2027 USD Mn)
8.1.5.5.3. Rest of Europe Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)

 

9. Asia Pacific Biopsy Guidance System Market Analysis and Forecast, 2018 – 2027 (USD Mn)


9.1.1. Overview
9.1.2. Asia Pacific Biopsy Guidance System Market by Product (2018-2027 USD Mn)
9.1.3. Asia Pacific Biopsy Guidance System Market by Application (2018-2027 USD Mn)
9.1.4. Asia Pacific Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)
9.1.5. Asia Pacific Biopsy Guidance System Market by Country (2018-2027 USD Mn)
9.1.5.1. China
9.1.5.1.1. China Biopsy Guidance System Market by Product (2018-2027 USD Mn)
9.1.5.1.2. China Biopsy Guidance System Market by Application (2018-2027 USD Mn)
9.1.5.1.3. China Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)
9.1.5.2. Japan
9.1.5.2.1. Japan Biopsy Guidance System Market by Product (2018-2027 USD Mn)
9.1.5.2.2. Japan Biopsy Guidance System Market by Application (2018-2027 USD Mn)
9.1.5.2.3. Japan Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)
9.1.5.3. Rest of Asia Pacific
9.1.5.3.1. Rest of Asia Pacific Biopsy Guidance System Market by Product (2018-2027 USD Mn)
9.1.5.3.2. Rest of Asia Pacific Biopsy Guidance System Market by Application (2018-2027 USD Mn)
9.1.5.3.3. Rest of Asia Pacific Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)

 

10. Latin America (LATAM) Biopsy Guidance System Market Analysis and Forecast, 2018 – 2027 (USD Mn)


10.1.1. Overview
10.1.2. Latin America Biopsy Guidance System Market by Product (2018-2027 USD Mn)
10.1.3. Latin America Biopsy Guidance System Market by Application (2018-2027 USD Mn)
10.1.4. Latin America Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)
10.1.5. Latin America Biopsy Guidance System Market by Country (2018-2027 USD Mn)
10.1.5.1. Brazil
10.1.5.1.1. Brazil Biopsy Guidance System Market by Product (2018-2027 USD Mn)
10.1.5.1.2. Brazil Biopsy Guidance System Market by Application (2018-2027 USD Mn)
10.1.5.1.3. Brazil Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)
10.1.5.2. Mexico
10.1.5.2.1. Mexico Biopsy Guidance System Market by Product (2018-2027 USD Mn)
10.1.5.2.2. Mexico Biopsy Guidance System Market by Application (2018-2027 USD Mn)
10.1.5.2.3. Mexico Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)
10.1.5.3. Rest of Latin America
10.1.5.3.1. Rest of Latin America Biopsy Guidance System Market by Product (2018-2027 USD Mn)
10.1.5.3.2. Rest of Latin America Biopsy Guidance System Market by Application (2018-2027 USD Mn)
10.1.5.3.3. Rest of Latin America Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)

 

11. Middle East and Africa Biopsy Guidance System Market Analysis and Forecast, 2018 – 2027 (USD Mn)


11.1.1. Overview
11.1.2. MEA Biopsy Guidance System Market by Product (2018-2027 USD Mn)
11.1.3. MEA Biopsy Guidance System Market by Application (2018-2027 USD Mn)
11.1.4. MEA Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)
11.1.5. Middle East and Africa Biopsy Guidance System Market, by Country (2018-2027 USD Mn)
11.1.5.1. GCC
11.1.5.1.1. GCC Biopsy Guidance System Market by Product (2018-2027 USD Mn)
11.1.5.1.2. GCC Biopsy Guidance System Market by Application (2018-2027 USD Mn)
11.1.5.1.3. GCC Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)
11.1.5.2. Rest of MEA
11.1.5.2.1. Rest of MEA Biopsy Guidance System Market by Product (2018-2027 USD Mn)
11.1.5.2.2. Rest of MEA Biopsy Guidance System Market by Application (2018-2027 USD Mn)
11.1.5.2.3. Rest of MEA Biopsy Guidance System Market by End-Use (2018-2027 USD Mn)

 

12. Company Profiles


12.1. Becton, Dickinson and Company
12.1.1. Business Description
12.1.2. Financial Health and Budget Allocation
12.1.3. Product Positions/Portfolio
12.1.4. Recent Development
12.1.5. SWOT Analysis
12.2. Hologic, Inc.
12.2.1. Business Description
12.2.2. Financial Health and Budget Allocation
12.2.3. Product Positions/Portfolio
12.2.4. Recent Development
12.2.5. SWOT Analysis
12.3. ARGON MEDICAL
12.3.1. Business Description
12.3.2. Financial Health and Budget Allocation
12.3.3. Product Positions/Portfolio
12.3.4. Recent Development
12.3.5. SWOT Analysis
12.4. B. Braun Melsungen AG
12.4.1. Business Description
12.4.2. Financial Health and Budget Allocation
12.4.3. Product Positions/Portfolio
12.4.4. Recent Development
12.4.5. SWOT Analysis
12.5. Devicor Medical Products, Inc.
12.5.1. Business Description
12.5.2. Financial Health and Budget Allocation
12.5.3. Product Positions/Portfolio
12.5.4. Recent Development
12.5.5. SWOT Analysis
12.6. Boston Scientific Corporation
12.6.1. Business Description
12.6.2. Financial Health and Budget Allocation
12.6.3. Product Positions/Portfolio
12.6.4. Recent Development
12.6.5. SWOT Analysis
12.7. INRAD Inc.
12.7.1. Business Description
12.7.2. Financial Health and Budget Allocation
12.7.3. Product Positions/Portfolio
12.7.4. Recent Development
12.7.5. SWOT Analysis
12.8. Cook Medical
12.8.1. Business Description
12.8.2. Financial Health and Budget Allocation
12.8.3. Product Positions/Portfolio
12.8.4. Recent Development
12.8.5. SWOT Analysis
12.9. PLANMED OY
12.9.1. Business Description
12.9.2. Financial Health and Budget Allocation
12.9.3. Product Positions/Portfolio
12.9.4. Recent Development
12.9.5. SWOT Analysis
Fill the given form to inquiry before buying for Biopsy Guidance System Market Report

Your Designtaion (required):


(Additional country analysis and conmapny analysis will be added according to the request, please read our FAQs below)
(Reports covers the COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying



Frequently Asked Questions (FAQs):
A. Yes, we provide customization with every report to fulfill your market research requirement.
A. No, generally we don’t charge for report customization.
A. Yes, we will add the more coutries analysis in the report, please mention the countries you are looking.
A. Yes, we provide research support for all our clients to resolve their issue regarding the report.
A. Yes, you can purchase only a regional or a country market report with our best price which is less than the global report.
A. Yes, we provide a better discount for startups and individuals.
A. Our database consists of over 70,000 market research reports; if still not available on the website, feel free to write us. Our team will be happy to assist you in the same. Let us know if you are looking for the dataset.
(For more information, feel free to write us at sales@researchcorridor.com)
Select License Type
$3600/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client are returning clients
  • 100,000+ data points in our comprehensive database
  • 24x5 availability - we are always there when you need us
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report

Impacts of COVID-19
COVID-19 Impact on the Biopsy Guidance System Market

For Any Assitance

Call Us: +1 520-686-7060
Email: sales@researchcorridor.com

Our Clients